Schizandrin attenuates inflammation induced by avian pathogenic Escherichia coli in chicken type II pneumocytes.

In conclusion, our findings revealed that schizandrin could reduce the inflammatory injury of chicken type II pneumocytes by reducing the adhesion of APEC-O78 to chicken type II pneumocytes. The results indicate that schizandrin can be a potential agent to treat inflammation caused by avian colibacillosis. PMID: 32070918 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32070918?dopt=Abstract

Source: International Immunopharmacology - February 14, 2020 Category: Allergy & Immunology Authors: Yuan M, Peng LY, Wu SC, Li JH, Song K, Chen S, Huang JN, Yu JL, An Q, Yi PF, Shen HQ, Fu BD Tags: Int Immunopharmacol Source Type: research